What is Lumen?
Founded in 2014 and headquartered in Tel Aviv, Israel, Lumen operates at the forefront of personalized nutrition and metabolism. The company leverages technology to empower individuals in improving their health and fitness, offering data-driven insights into their metabolic state. This approach positions Lumen as a key player in the rapidly expanding digital health and wellness market, catering to a growing demand for personalized health solutions.
How much funding has Lumen raised?
Lumen has raised a total of $62M across 1 funding round:
Series B
$62M
Series B (2022): $62M with participation from RiverPark Ventures, Pitango Venture Capital, Resolution Ventures, Hanwha Group, Almeda Ventures, Disruptive VC, and Unorthodox Ventures
Key Investors in Lumen
RiverPark Ventures
RiverPark Ventures is an early-stage venture capital fund founded by entrepreneurs to invest in entrepreneurs, forming part of the RiverPark family of funds managing over $3 billion in assets.
Pitango Venture Capital
Pitango is a venture capital firm that partners with visionary entrepreneurs and groundbreaking companies across its First, Growth, and HealthTech funds, providing value-added support from stealth mode to maturity.
Resolution Ventures
Resolution Ventures backs early-stage Fintech companies in Southeast Asia with international ambitions, focusing on solutions that address financial inclusion and infrastructure challenges.
What's next for Lumen?
The recent major strategic investment signals a pivotal phase for Lumen, likely enabling the company to accelerate its product development, expand its market reach, and further innovate in the personalized nutrition space. This capital infusion is expected to fuel strategic initiatives aimed at solidifying its leadership position and exploring new avenues for growth within the health-tech industry. The company's focus on metabolism and personalized insights suggests a future geared towards deeper integration of technology into daily wellness routines.
See full Lumen company page